These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4205080)

  • 21. Quantitation of the cell-mediated immune response. I. The number of cytolytically active mouse lymphoid cells induced by immunization with allogeneic mastocytoma cells.
    Henney CS
    J Immunol; 1971 Dec; 107(6):1558-66. PubMed ID: 5000987
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of macrophages in the cytotoxic killing of tumour cells in vitro. I. Primary immunization of lymphocytes in vitro for target cell killing and the mechanism of lymphocyte-macrophage cooperation.
    Zembala M; Ptak W; Hanczakowska M
    Immunology; 1973 Oct; 25(4):631-44. PubMed ID: 4356674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative in vitro studies on effector cell diversity in the cellular immune response to murine sarcoma virus (MSV)-induced tumors in mice.
    Plata F; Gomard E; Leclerc JC; Levy JP
    J Immunol; 1974 Apr; 112(4):1477-87. PubMed ID: 4360862
    [No Abstract]   [Full Text] [Related]  

  • 24. The kinetics of Cr release from target cells in cell mediated cytotoxicity and the relationship to the kinetics of killing.
    Sanderson CJ; Taylor GA
    Cell Tissue Kinet; 1975 Jan; 8(1):23-32. PubMed ID: 803411
    [No Abstract]   [Full Text] [Related]  

  • 25. Cortisone-resistant thymocytes as target cells in lymphocyte-mediated cytolysis.
    Ritter J; Lohmann-Matthes ML
    J Immunol Methods; 1974 Jul; 5(2):209-12. PubMed ID: 4209331
    [No Abstract]   [Full Text] [Related]  

  • 26. [Target cell destruction by sensitized lymphocytes (author's transl)].
    Hashimoto Y; Kitagawa H
    Tanpakushitsu Kakusan Koso; 1974 Sep; 19(10):907-15. PubMed ID: 4216047
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of cytostatic hexitol derivatives on haematopoietic stem cells, the L1210 leukaemia and C22LR osteosarcoma.
    Fuzy M; Lelieveld P; Van Putten LM
    Eur J Cancer (1965); 1975 Mar; 11(3):169-73. PubMed ID: 165939
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on the mechanism of lymphocyte-mediated cytolysis. II. The use of various target cell markers to study cytolytic events.
    Henney CS
    J Immunol; 1973 Jan; 110(1):73-84. PubMed ID: 4631074
    [No Abstract]   [Full Text] [Related]  

  • 29. [Studies on the properties of a factor isolated from a mastocytic tumor of mice].
    Goldman WF; Girard JP; Maurice PA
    Schweiz Med Wochenschr; 1972 Aug; 102(33):1184-6. PubMed ID: 4626633
    [No Abstract]   [Full Text] [Related]  

  • 30. Effector mechanisms of cell-mediated immunity to xenogeneic cell antigens.
    Dennert G
    J Immunol; 1974 Jul; 113(1):201-8. PubMed ID: 4208918
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of irradiated and mitomycin-treated mouse spleen cells as stimulating cells in mixed lymphocyte cultures and in vitro sensitization.
    Hodes RJ; Terry WD
    J Immunol; 1974 Jul; 113(1):39-44. PubMed ID: 4275549
    [No Abstract]   [Full Text] [Related]  

  • 32. Estimation of the size of a T-cell-induced lytic lesion.
    Henney CS
    Nature; 1974 May; 249(456):456-8. PubMed ID: 4209916
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cytochalasin B is an inhibitor of the cytotoxic activity of sensitized lymphoid cells].
    Degiovanni G
    C R Seances Soc Biol Fil; 1972; 166(4):736-40. PubMed ID: 4631303
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of organophosphorus inhibitors, p-nitrophenol and cytochalasin B on cytotoxic killing of tumour cells by immune spleen cells, and the effect of shaking.
    Ferluga J; Asherson GL; Becker EL
    Immunology; 1972 Oct; 23(4):577-90. PubMed ID: 4628464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxic lymphocytes in Hashimoto's thyroiditis.
    Podleski WK
    Clin Exp Immunol; 1972 Aug; 11(4):543-8. PubMed ID: 4628576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes.
    Rouse BT; Wagner H; Harris AW
    J Immunol; 1972 May; 108(5):1353-61. PubMed ID: 4623947
    [No Abstract]   [Full Text] [Related]  

  • 37. Membrane properties and functional activity of lymphocytes from cyclophosphamide-pretreated rats.
    Guttmann RD
    J Immunol; 1974 Apr; 112(4):1594-601. PubMed ID: 4273628
    [No Abstract]   [Full Text] [Related]  

  • 38. A glycopeptide extract can inhibit cytotoxic T lymphocyte-target cell conjugation in an H-2-restricted manner.
    Pimlott NJ; Miller RG
    J Immunol; 1984 Oct; 133(4):1763-8. PubMed ID: 6236257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for several cell populations active in antibody dependent cellular cytotoxicity.
    Zighelboim J; Bonavida B; Fahey JL
    J Immunol; 1973 Dec; 111(6):1737-42. PubMed ID: 4750865
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of phytohemagglutinin on the cytotoxic activity of lymphocytes].
    Artsimovich NG; Shalyminova IuA; Fadeeva TA; Zakharova TE
    Dokl Akad Nauk SSSR; 1980; 253(3):751-2. PubMed ID: 7428599
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.